Oligodendroglioma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
* [[N-acetyl aspartate]] (NAA) peak is dominant | * [[N-acetyl aspartate]] (NAA) peak is dominant | ||
*[[Choline]]-to-[[creatine]] ratio of less than 3:1 | *[[Choline]]-to-[[creatine]] ratio of less than 3:1 | ||
*Reduction of [[N | *Reduction of [[N acetylaspartic acid|NAA]]/[[creatine]] ratio | ||
==References== | ==References== | ||
Revision as of 18:08, 12 October 2015
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma other imaging findings |
|
Risk calculators and risk factors for Oligodendroglioma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Other Imaging Findings
Other imaging studies for oligodendroglioma include:[1]
Magnetic Resonance Spectroscopy
- N-acetyl aspartate (NAA) peak is dominant
- Choline-to-creatine ratio of less than 3:1
- Reduction of NAA/creatine ratio
References
- ↑ Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.